Vimarsana
Biggest News Aggregation in the World

Page 15 - Iontech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iontech Today - Breaking & Trending Today

BioNTech : Report of the Supervisory Board on the 2022 financial year - Vimarsana News

BioNTech : Report of the Supervisory Board on the 2022 financial year

Report of the Supervisory Board on the financial year 2022 The 2022 financial year was a significant and challenging year for BioNTech SE. The Management Board,... | April 13, 2023

BioNTech : Joint report of the Management Board of BioNTech SE and the management of BioNTech Individualized mRNA Manufacturing GmbH on the domination and profit and loss transfer agreement pursuant to Sec. 293a of the German Stock Corporation Act - Vimarsana News

BioNTech : Joint report of the Management Board of BioNTech SE and the management of BioNTech Individualized mRNA Manufacturing GmbH on the domination and profit and loss transfer agreement pursuant to Sec. 293a of the German Stock Corporation Act

English Convenience Translation - the German language joint report is decisive Joint report of the Management Board of BioNTech SE, Mainz, and the management of... | April 13, 2023

BioNTech : Proxy form, power of attorney and instruction form - Vimarsana News

BioNTech : Proxy form, power of attorney and instruction form

Please turn to give instructions. ► Registration and proxy form Ordinary General Meeting of BioNTech SE on 25 May... | April 13, 2023

Texarkana Arkansas Board of Directors appoint Acting City Manager - Vimarsana News

Texarkana Arkansas Board of Directors appoint Acting City Manager

TEXARKANA, Ark. – The Texarkana Arkansas Board of Directors met on Monday to appoint TyRhonda Henderson, the city’s financial director, to temporarily fill the vacancy of city manager until a

Source: ktbs.com
Arbutus Biopharma Sues Pfizer, BioNTech Over Alleged Patent Infringement - Vimarsana News

Arbutus Biopharma Sues Pfizer, BioNTech Over Alleged Patent Infringement

By Will Feuer Arbutus Biopharma Corp. and its licensee Genevant Sciences have filed a patent-infringement lawsuit against Pfizer Inc. and BioNTech SE related to the latter's Covid-19 vaccine.... | April 4, 2023